« Previous
Next »
Brachytherapy
Volume 5, Issue 4
, Pages 251-255
, October 2006
Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma
References
- . The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol). 2005;17:219–227
- GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol. 2005;74:137–148
- Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favourable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys. 2001;49:61–69
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 2000;48:675–681
- The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
- The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. Radiother Oncol. 2000;57:279–284
- A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:515–524
- . A dose homogeneity index for evaluating 192Ir interstitial breast implant. Med Phys. 1988;15:104–107
- Dosimetry and cancer control after low-dose-rate prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;61:52–59
- Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V(100) superior to D(90)?. Brachytherapy. 2005;4:252–258
- Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?. Int J Radiat Oncol Biol Phys. 2006;64:825–834
- . Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors. Brachytherapy. 2004;3:10–19
- Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:1063–1067
- 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: A dosimetric point of view. Radiother Oncol. 2006;78:47–52
- Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Int J Radiat Oncol Biol Phys. 2002;54:86–100
- A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1998;41:101–108
- . Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32:465–471
- Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;55:956–963
- Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2004;59:1196–1207
PII: S1538-4721(06)00243-1
doi: 10.1016/j.brachy.2006.08.006
© 2006 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Brachytherapy
Volume 5, Issue 4
, Pages 251-255
, October 2006
